Chemerin-9
- Category
- Weight Management & Metabolic
- Regulatory status
- Not FDA-approved
What it is
A 9-amino-acid fragment of the adipokine chemerin, marketed for immune modulation, fat metabolism, and antimicrobial skin effects via the ChemR23 receptor. The case rests on mechanism and cell studies only, with no controlled human trials, and even those effects are rated low confidence or speculative. There is no human safety data, and a pro-inflammatory effect at high doses is unresolved. Not an approved drug, sold as unregulated research-grade material.
Read Full recordStudied uses & evidence
Studied uses(3)
Chemoattractant for immune cells (dendritic cells, macrophages, NK cells) via CMKLR1
LowDocumented mainly for full-length chemerin in vitro and in mice, not this fragment in humans.
Full agonist activity at CMKLR1 — minimal functional fragment for receptor activation
LowReceptor binding and activation are well characterized structurally, with no demonstrated human benefit.
Regulation of adipogenesis and energy metabolism through CMKLR1 in adipose tissue
LowAnimal and cell studies show metabolic effects via this receptor; human data are lacking.
Evidence limits
- Evidence Level
- Early Research (Preclinical Only, No Human Trials)
Chemerin-9 is purely a research peptide with no human clinical trials. All evidence comes from in-vitro cell culture, structural biology (cryo-EM), and animal models. The cited antimicrobial skin-infection findings concern p4, not chemerin-9. Metabolic associations come from observational human studies measuring circulating chemerin levels, not from chemerin-9 administration. The structural and mechanistic understanding is strong, but therapeutic translation is in very early stages.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
General cautions
Pregnancy or breastfeeding
AbsoluteNo human reproductive safety data exists for this peptide. Effects on fetal development are unknown.
Children under 18
AbsoluteNo pediatric safety data. Not recommended for use in minors.
Known hypersensitivity
AbsoluteDiscontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).
Risk summary(3)
Risks = level of concern: High · Moderate · Low · Theoretical
No human safety data available
HighPotential pro-inflammatory effects at high concentrations
ModerateMetabolic effects uncertain
Moderate
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.